Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in CLLS — Cellectis S.A.

CIK 72971 SAN FRANCISCO, CA
Back to CLLS Full portfolio

Position in CLLS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,450
-$535 QoQ
Shares Held
3,150
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 27 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CLLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. CLLS ranks #318 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in CLLS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,450 3,150
2026-03-31 $9,985 3,150
2025-12-31 $15,246 3,150
2025-09-30 $8,977 3,150
2025-06-30 $26,153 17,150
2025-03-31 $28,210 22,750
2024-12-31 $44,262 24,590
2024-09-30 $25,630 12,090
2024-06-30 $23,917 12,790
2024-03-31 $34,291 12,940
2023-12-31 $44,025 14,294
2023-09-30 $24,559 15,544
2023-06-30 $31,327 15,919
2023-03-31 $31,804 16,479
2022-12-31 $35,655 16,979
2022-09-30 $39,453 17,229
2022-06-30 $33,476 11,829
2022-03-31 $58,697 12,929
2021-12-31 $158,111 19,472
2021-09-30 $423,947 33,620
2021-06-30 $447,545 28,930
2021-03-31 $615,837 30,472
2020-12-31 $726,073 26,832
2020-09-30 $521,644 28,197
2020-06-30 $549,449 30,868
2020-03-31 $350,077 38,052